As shown in our results, CCL20 treatment of the SAS and FaDu cells could increase their migration and proliferation effects and restore mTOR signaling pathway activation in HNSCC cells, but the combination of CCL20 and mTOR inhibitor treatment failed to produce these phenomena. This evidence concerns the gene MTOR and head and neck squamous cell carcinoma.